Loading people...
Clara Burtenshaw is a Partner and Co-Founder at Neo Kuma Ventures, Europe's first dedicated psychedelic healthcare venture capital fund, based in London, the United Kingdom. She co-launched the £20 million investment vehicle in late 2019 to write £150,000 to £1 million checks for pre-seed through Series A biotechnology startups. Her portfolio includes early investments in prominent life sciences companies such as ATAI Life Sciences and Compass Pathways, both of which subsequently completed high-profile public offerings on the NASDAQ. Before transitioning to venture capital, she spent five years as a General Counsel for a private equity-backed retail group and five years handling mergers, acquisitions, and corporate finance at Slaughter and May. An alumna of Oxford University, Burtenshaw currently focuses on financing science-led teams developing clinical psychedelic therapies and digital tools for treating severe mental health disorders.
Clara Burtenshaw is a distinguished Partner at Neo Kuma Ventures, a prominent venture capital firm known for its forward-thinking approach to early-stage technology investments. In her role, Clara is instrumental in sourcing, evaluating, and leading investment rounds for companies that demonstrate exceptional potential to redefine their respective industries. Her strategic insights and deep understanding of market dynamics make her a valuable asset to both Neo Kuma Ventures and its diverse portfolio of innovative startups.
Clara's investment focus at Neo Kuma Ventures spans a range of high-growth sectors, including but not limited to artificial intelligence, B2B SaaS, fintech, digital health, and the future of work. She is particularly passionate about disruptive technologies that offer scalable solutions to complex problems, seeking out founders with strong vision and execution capabilities. Clara believes in a hands-on approach, working closely with portfolio companies to provide strategic guidance, facilitate network connections, and support their journey from nascent ideas to market leaders. Her commitment extends beyond capital, aiming to build lasting partnerships that foster sustainable growth and innovation.
Prior to her tenure at Neo Kuma Ventures, Clara Burtenshaw built a robust career foundation in the technology and finance sectors. Her background includes experience in strategic consulting, where she advised numerous tech companies on market entry and growth strategies, as well as roles in corporate development for fast-growing startups. This diverse experience equipped her with a comprehensive understanding of operational challenges and strategic opportunities within the startup ecosystem. Her journey into venture capital was a natural progression, driven by a desire to directly impact the next generation of technological advancements.
While specific individual investments are often a collaborative effort within a venture capital firm, Clara Burtenshaw has been a key contributor to Neo Kuma Ventures' successful portfolio. She has been instrumental in identifying companies that align with the firm's thesis of investing in transformative technologies. Her contributions have helped shape the firm's investment strategy and solidify its reputation as a leading investor in the early-stage tech landscape. Clara's keen eye for innovation and her dedication to supporting entrepreneurial talent continue to drive significant value for Neo Kuma Ventures and its stakeholders.
Clara Burtenshaw is a Partner at Neo Kuma Ventures, a venture capital firm. She specializes in identifying, evaluating, and leading early-stage technology investments, working closely with founders to scale innovative companies.
Clara Burtenshaw focuses on early-stage technology investments across various high-growth sectors. Her interests include artificial intelligence, B2B SaaS, fintech, digital health, and companies shaping the future of work, particularly those offering disruptive and scalable solutions.
Clara Burtenshaw works as a Partner at Neo Kuma Ventures. This venture capital firm is dedicated to investing in and supporting groundbreaking technology startups.
